Page last updated: 2024-08-17

prednisone and oblimersen

prednisone has been researched along with oblimersen in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Klasa, RJ	1

Reviews

1 review(s) available for prednisone and oblimersen

Article	Year
Targeting the proapoptotic factor Bcl-2 in non-Hodgkin's lymphoma. Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 1 Topics: Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Gene Expression Regulation, Leukemic; Humans; Lymphoma, Non-Hodgkin; Oligonucleotides, Antisense; Prednisone; Proto-Oncogene Proteins c-bcl-2; Remission Induction; Rituximab; RNA, Messenger; Survival Analysis; Thionucleotides; Transplantation, Heterologous; Vincristine	2004

Article

Year

Targeting the proapoptotic factor Bcl-2 in non-Hodgkin's lymphoma.

Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 1

Topics: Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Gene Expression Regulation, Leukemic; Humans; Lymphoma, Non-Hodgkin; Oligonucleotides, Antisense; Prednisone; Proto-Oncogene Proteins c-bcl-2; Remission Induction; Rituximab; RNA, Messenger; Survival Analysis; Thionucleotides; Transplantation, Heterologous; Vincristine

2004